US 12,716,059

Application 17/930,965 · Granted Aug 25, 2026

Immobilized proteases for activation of the zymogen form of transglutaminase

Estimated expiration

November 3, 2043

16y 351d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Sep 9, 2022
+ 20 years
Sep 9, 2042
PTA +420d
Nov 3, 2043
No TD
—
Final
Nov 3, 2043

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
September 9, 2022
Earliest effective filing
September 9, 2022
Issue date
August 25, 2026
PTA
+420 days
Base expiry (before PTA)
September 9, 2042

September 9, 2022 + 20 years = September 9, 2042 + 420 PTA days = November 3, 2043

Continuity chain

No continuity chain; the patent’s own filing date was used.

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/930,965 · US 12,716,059

PatentReply compiles the prosecution history behind US 12,716,059: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12716059

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.